Nuclear Medicine: Page 174

Shine wraps up NRC filing for medical isotope facility

By AuntMinnie.com staff writers

Medical isotope firm Shine Medical Technologies has submitted the remaining chapters of its construction permit application to the U.S. Nuclear Regulatory Commission (NRC).

June 4, 2013

FDG-PET/CT beats FLT-PET/CT for differentiated thyroid cancer

By Wayne Forrest

In a face-off of two PET radiopharmaceuticals, FDG-PET/CT outperformed F-18 fluorothymidine (FLT) PET/CT in the diagnosis of postoperative thyroid cancer lymph-node and distant metastases, making the hybrid modality more suitable for examining disease recurrence, according to a study in the June issue of Radiology.

June 4, 2013

MILabs to present SPECT/PET/CT/MRI system at SNMMI

By AuntMinnie.com staff writers

Preclinical imaging technology developer MILabs will showcase new MRI capabilities at the upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Vancouver, British Columbia.

June 3, 2013

Navidea touts SNMMI 2013 presentations

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals said that studies involving its Lymphoseek and NAV4694 radiopharmaceuticals will be presented at the upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 3, 2013

PET shows education's benefit in Alzheimer's

By AuntMinnie.com staff writers

PET images showed that highly educated individuals with mild cognitive impairment who later progressed to Alzheimer's disease coped better with the disease than individuals with a lower level of education, according to a study in the June issue of the Journal of Nuclear Medicine.

June 2, 2013

GE touts DaTscan studies at SNMMI

By AuntMinnie.com staff writers

GE Healthcare said that three studies utilizing its DaTscan tracer and investigational imaging agent flutemetamol will be presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

May 29, 2013